The Cooper Companies, Inc. $COO Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP raised its position in The Cooper Companies, Inc. (NASDAQ:COO) by 14.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,760,875 shares of the medical device company’s stock after buying an additional 223,169 shares during the period. Dimensional Fund Advisors LP owned about 0.89% of Cooper Companies worth $120,712,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of COO. Buckhead Capital Management LLC boosted its position in Cooper Companies by 14.3% during the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after purchasing an additional 7,368 shares in the last quarter. First American Bank purchased a new stake in shares of Cooper Companies in the third quarter valued at approximately $1,646,000. Rakuten Investment Management Inc. acquired a new position in shares of Cooper Companies during the 3rd quarter worth approximately $11,341,000. Amundi raised its stake in shares of Cooper Companies by 35.5% during the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock worth $97,225,000 after buying an additional 348,652 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Cooper Companies by 96.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after buying an additional 1,525,693 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was bought at an average price of $82.50 per share, for a total transaction of $165,000.00. Following the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. The trade was a 34.62% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Cynthia L. Lucchese bought 1,784 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was acquired at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the purchase, the director directly owned 9,445 shares in the company, valued at approximately $793,946.70. This represents a 23.29% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders bought 16,014 shares of company stock valued at $1,304,416. Company insiders own 2.08% of the company’s stock.

Cooper Companies Stock Down 0.9%

NASDAQ COO opened at $73.75 on Thursday. The business has a fifty day moving average price of $81.66 and a 200 day moving average price of $76.00. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The company has a market cap of $14.39 billion, a P/E ratio of 36.51, a P/E/G ratio of 1.92 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the company posted $0.92 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently issued reports on COO. Mizuho set a $100.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Friday, December 5th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 price objective on shares of Cooper Companies in a report on Friday, January 9th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Needham & Company LLC boosted their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Finally, Morgan Stanley upped their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average price target of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.